Screening and management of hospital hyperglycemia in non-critical patients: a position statement from the Brazilian Diabetes Society (SBD)

Table 4 Suggested blood glucose correction scale insulin*

Capillary blood glucose	Sensitive¹	Usual²	Resistant³
141–180 mg/dL	No Supplemental Dose	Increase by 1 IU	Increase by 2 IU
181–220 mg/dL	Increase by 1 IU	Increase by 2 IU	Increase by 4 IU
221–260 mg/dL	Increase by 1 IU	Increase by 3 IU	Increase by 6 IU
261–300 mg/dL	Increase by 2 IU	Increase by 4 IU	Increase by 8 IU
301–340 mg/dL	Increase by 2 IU	Increase by 5 IU	Increase by 10 IU
341–380 mg/dL	Increase by 3 IU	Increase by 6 IU	Increase by 12 IU
381–420 mg/dL	Increase by 3 IU	Increase by 7 IU	Increase by 14 IU
>420 mg/dL	Increase by 4 IU	Increase by 8 IU	Increase by 16 IU

CF correction factor, GTR blood glucose target range
^*Short-acting insulin or rapid-acting or ultra-rapid analogs. In the case of continuous enteral or parenteral feeding, correction can be performed every 4–6 h
(1) Sensitive (CF 80 mg/dL and GTR 100–140 mg/dL): indicated for elderly patients, or with a body mass index (BMI) < 19 kg/m², frail and/or with kidney, liver or heart failure
(2) Usual (CF 40 mg/dL and GTR 100–140 mg/dL): indicated for patients with BMI between 19 and 33 kg/m², without signs of insulin resistance or use of glucocorticoids
(3) Resistant (CF 20 mg/dL and GTR 100–140 mg/dL): indicated for patients with BMI above 33 kg/m², with signs of insulin resistance, using glucocorticoids, or persistently elevated blood glucose levels

ISSN: 1758-5996